| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 154.06 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Ramsey pricing has been proposed in the pharmaceutical industry as a
principle to price discriminate among markets while allowing to recover the
(fixed) R&D cost. However, such analyses neglect the presence of insurance
or the fund raising costs for most of drug reimbursement. By incorporating
these new elements, we aim at providing some building blocks towards
an economic theory incorporating Ramsey pricing and insurance coverage.
We show how coinsurance affects the optimal prices to pay for the R&D investment.
We also show that under certain conditions, there is no strategic
incentive by governments to set coinsurance rates in order to shift the financial
burden of R&D. This will have important implications to the application
of Ramsey pricing principles to pharmaceutical products across countries.
Descrição
Palavras-chave
Ramsey pricing, coinsurance.
Contexto Educativo
Citação
Editora
Springer Netherlands
